Latest current cash for SCPH: $41M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
scPharmaceuticals (SCPH) currently reports a current cash of $41M as of June 2025. That compares with $39M in the prior-year period — up 6.0% year over year. Use the charts on this page to explore scPharmaceuticals's current cash history and peer comparisons.
scPharmaceuticals's current cash increased from $39M to $41M — a 6.0% year-over-year increase (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
scPharmaceuticals reported $41M in current cash as of June 2025. That compares with $39M in the prior-year period — up 6.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current cash of $41M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for scPharmaceuticals, and consider following SCPH for alerts when major investors trade the stock.
scPharmaceuticals is classified in the Healthcare sector. On current cash, it currently shows $41M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SCPH with unrelated industries.